nektar therapeutics

nektar therapeutics

NASDAQ:NKTR

Chart

Detailed Quote

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India.
Featured Articles and Interviews
Large pharmaceutical pill with gold dollar sign in the middle. Stock tickers and charts are in the background.

Top 5 NASDAQ Pharma Stocks (Updated July 2024)

Press Releases

Nektar Therapeutics Reports First Quarter 2026 Financial Results

Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

The Conversation (0)